1. HDL is complex and has multiple functions.
2. HDL deficiency is mostly secondary
3. HDL cholesterol efflux and anti-inflammation actions relevant to outcomes.
4. New methods (e.g., MUS studies) are required to assess HDL-related therapies.
Dr. Anthony Wierzbicki is a Consultant in metabolic medicine/chemical pathology at Guy's and St Thomas' NHS Foundation. He Completed DM University of Oxford 2004, Fellow Royal College of Pathologists 2001, DPhil University of Oxford 1992, BMBCh University of Oxford 1986, BA (MA), University of Cambridge (1983-1987), Honorary professor in Lipids & Cardiometabolic Disease at King's College London, 2014. Lecturer and honorary senior registrar in chemical pathology at Imperial College Medical School, London, 1992-1995.
Subscribe To Our Newsletter
Filter out the noise and nurture your inbox with health and wellness advice that's inclusive and rooted in medical expertise.
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please update your details